FlandersBio on Twitter

Follow us on Twitter

Board of Directors

Raad van Bestuur

in het nederlands in english

FlandersBio’s board of directors is composed of representatives from different life sciences companies, research institutes, and providers of capital & services.

De raad van bestuur van FlandersBio samengesteld met vertegenwoordigers uit verschillende bedrijven, onderzoekscentra, investeerders en dienstverlenende bedrijven werkzaam in de life sciences sector in Vlaanderen.

Board of Directors

Aratana Therapeutics, represented by Erwin Blomsma

Aratana Therapeutics, represented by Erwin Blomsma

eTherna, represented by Dirk Reyn

eTherna, represented by Dirk Reyn

Bayer CropScience, represented by Johan Botterman

Bayer CropScience, represented by Johan Botterman

VIB, represented by Johan Cardoen

VIB, represented by Johan Cardoen

Genzyme, represented by Jo Dalle

Genzyme, represented by Jo Dalle

PMV NV, represented by Chris De Jonghe

PMV NV, represented by Chris De Jonghe

imec, represented by Jo De Boeck

imec, represented by Jo De Boeck

Nathalie Van Den Haute, nominated by KBC Securities

Nathalie Van Den Haute, nominated by KBC Securities

Ablynx, represented by Johan Heylen

Ablynx, represented by Johan Heylen

CropDesign, represented by Jürgen Logemann

CropDesign, represented by Jürgen Logemann

Antleron, represented by Jan Schrooten

Antleron, represented by Jan Schrooten

Merck Millipore, represented by Mieke Van Acker

Merck Millipore, represented by Mieke Van Acker

Quality by Design, represented by Bart Van Acker

Quality by Design, represented by Bart Van Acker

Patrick Van Beneden, nominated by Gimv

Patrick Van Beneden, nominated by Gimv

Biomaric, represented by Hugo Van Heuverswyn

Biomaric, represented by Hugo Van Heuverswyn

Cochlear, represented by Carl Van Himbeeck

Cochlear, represented by Carl Van Himbeeck

Albert Van Loo, nominated by Genencor International BVBA

Albert Van Loo, nominated by Genencor International BVBA

Gert Vanhees, nominated by Deloitte

Gert Vanhees, nominated by Deloitte

Advisor to the Board

Observer

Dirk Veelaert

Dirk Veelaert

Back to top

Print